SF0166 is a potent and selective inhibitor of integrin αvβ3 which inhibits integrin-ligand interactions and cellular adhesion to vitronectin across human, rat, rabbit, and dog cell lines. References: Askew BC, Furuya T, Edwards DS. Ocular Distribution and Pharmacodynamics of SF0166, a Topically Administered α(v)β(3) Integrin Antagonist, for the Treatment of Retinal Diseases. J Pharmacol Exp Ther. 2018 Aug;366(2):244-250. doi: 10.1124/jpet.118.248427. Epub 2018 May 31. PubMed PMID: 29853477.

纯度：≥98%

CAS：1621332-91-9